E. V. von Euw

Extracellular Acidosis Triggers the Maturation of Human Dendritic Cells and the Production of IL-121

S. Amigorena, J. Sabatté, A. Ceballos, 2007, The Journal of Immunology.

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

R. Finn, D. Slamon, L. Anderson, 2013, International journal of molecular sciences.

Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.

P. Spellman, G. Mills, J. Gray, 2020, Cancer cell.

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

P. Spellman, G. Mills, J. Gray, 2020, bioRxiv.

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

A. Ribas, S. Rosenberg, U. Hegde, 2010, Clinical immunology.

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

D. Furman, C. Yee, O. Lantz, 2008, Journal of Translational Medicine.

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

A. Belldegrun, J. Christensen, F. Kabbinavar, 2013, Anticancer research.